Variant report

Variant	esv1796032
Chromosome Location	chr17:20432140-20446160
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:223)
CpG islands
(count:122)
Chromatin interactive
region (count:0)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:223 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr17:20443556-20444223	GM12878	blood:	n/a	n/a
2	BATF	chr17:20443708-20444186	GM12878	blood:	n/a	n/a
3	BCL11A	chr17:20443676-20444145	GM12878	blood:	n/a	n/a
4	BCL11A	chr17:20443777-20444111	GM12878	blood:	n/a	n/a
5	BCL3	chr17:20438566-20438789	GM12878	blood:	n/a	n/a
6	CEBPB	chr17:20432904-20432946	K562	blood:	n/a	n/a
7	CEBPB	chr17:20432878-20433065	A549	lung:	n/a	chr17:20432946-20432955 chr17:20432944-20432957 chr17:20432944-20432955
8	CEBPB	chr17:20432902-20433054	IMR90	lung:	n/a	chr17:20432946-20432955 chr17:20432944-20432957 chr17:20432944-20432955
9	CHD1	chr17:20434510-20434553	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr17:20445589-20445738	LNCaP	prostate:	n/a	n/a
11	CTCF	chr17:20445620-20445770	AG10803	skin:	n/a	n/a
12	CTCF	chr17:20445632-20445687	Hela-S3	cervix:	n/a	n/a
13	CTCF	chr17:20445558-20445742	Pancreas_OC	pancreas:	n/a	n/a
14	CTCF	chr17:20445580-20445730	SAEC	small airway:	n/a	n/a
15	CTCF	chr17:20445593-20445750	NHEK	skin:	n/a	n/a
16	CTCF	chr17:20440911-20440950	Pancreas_OC	pancreas:	n/a	n/a
17	CTCF	chr17:20445642-20445704	GM10266	blood:	n/a	n/a
18	CTCF	chr17:20445622-20445689	GM12878	blood:	n/a	n/a
19	CTCF	chr17:20445600-20445750	MCF-7	breast:	n/a	n/a
20	CTCF	chr17:20445580-20445730	HEEpiC	esophagus:	n/a	n/a
21	CTCF	chr17:20445580-20445730	AG09309	skin:	n/a	n/a
22	CTCF	chr17:20445599-20445741	ProgFib	skin:	n/a	n/a
23	CTCF	chr17:20445637-20445731	Fibrobl	skin:	n/a	n/a
24	CTCF	chr17:20445654-20445703	LNCaP	prostate:	n/a	n/a
25	CTCF	chr17:20445604-20445730	MCF-7	breast:	n/a	n/a
26	CTCF	chr17:20445610-20445723	MCF-7	breast:	n/a	n/a
27	CTCF	chr17:20435634-20435680	Pancreas_OC	pancreas:	n/a	n/a
28	CTCF	chr17:20445580-20445730	AG09319	gingival:	n/a	n/a
29	CTCF	chr17:20445558-20445726	T-47D	breast:	n/a	n/a
30	CTCF	chr17:20445560-20445710	AG04449	skin:	n/a	n/a
31	CTCF	chr17:20435522-20435586	Kidney_OC	kidney:	n/a	n/a
32	CTCF	chr17:20445560-20445710	AG10803	skin:	n/a	n/a
33	CTCF	chr17:20445520-20445670	HMEC	breast:	n/a	n/a
34	CTCF	chr17:20445580-20445730	HMEC	breast:	n/a	n/a
35	CTCF	chr17:20445580-20445730	Caco-2	colon:	n/a	n/a
36	CTCF	chr17:20445560-20445710	HRPEpiC	eye:	n/a	n/a
37	CTCF	chr17:20445620-20445770	AG09319	gingival:	n/a	n/a
38	EBF1	chr17:20435359-20435676	GM12878	blood:	n/a	n/a
39	EBF1	chr17:20443599-20444220	GM12878	blood:	n/a	chr17:20444093-20444102 chr17:20444093-20444103
40	EBF1	chr17:20435231-20435789	GM12878	blood:	n/a	n/a
41	EBF1	chr17:20443620-20444226	GM12878	blood:	n/a	chr17:20444093-20444102 chr17:20444093-20444103
42	EGR1	chr17:20436494-20436801	H1-hESC	embryonic stem cell:	n/a	n/a
43	EGR1	chr17:20435348-20435471	GM12878	blood:	n/a	chr17:20435367-20435381 chr17:20435385-20435399
44	EGR1	chr17:20435332-20435489	K562	blood:	n/a	chr17:20435367-20435381 chr17:20435385-20435399
45	EGR1	chr17:20436571-20436799	H1-hESC	embryonic stem cell:	n/a	n/a
46	EGR1	chr17:20435357-20435463	GM12878	blood:	n/a	chr17:20435367-20435381 chr17:20435385-20435399
47	EP300	chr17:20444145-20444524	T-47D	breast:	n/a	n/a
48	EP300	chr17:20443863-20444125	GM12878	blood:	n/a	n/a
49	FOXA1	chr17:20438413-20438715	HepG2	liver:	n/a	n/a
50	FOXA1	chr17:20444181-20444516	T-47D	breast:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:20433187-20433237	HL-60	blood:	n/a
2	chr17:20445757-20445807	NB4	blood:	n/a
3	chr17:20433187-20433237	HepG2	liver:	n/a
4	chr17:20445757-20445807	ProgFib	skin:	n/a
5	chr17:20445757-20445807	PrEC	prostate:	n/a
6	chr17:20445757-20445807	H1-hESC	embryonic stem cell:	embryo
7	chr17:20445757-20445807	MCF10A-Er-Src	breast:	n/a
8	chr17:20433187-20433237	ProgFib	skin:	n/a
9	chr17:20445757-20445807	K562	blood:	n/a
10	chr17:20445757-20445807	HEK293	kidney:	embryo
11	chr17:20433187-20433237	GM06990	blood:	n/a
12	chr17:20433187-20433237	HIPEpiC	eye:	n/a
13	chr17:20433187-20433237	HMEC	breast:	n/a
14	chr17:20445757-20445807	SAEC	small airway:	n/a
15	chr17:20433187-20433237	HEK293	kidney:	embryo
16	chr17:20445757-20445807	HCF	heart:	n/a
17	chr17:20433187-20433237	HAEpiC	amniotic membrane:	n/a
18	chr17:20433187-20433237	Hela-S3	cervix:	n/a
19	chr17:20445757-20445807	T-47D	breast:	n/a
20	chr17:20433187-20433237	NH-A	brain:	n/a
21	chr17:20433187-20433237	SK-N-MC	brain:	n/a
22	chr17:20433187-20433237	A549	lung:	n/a
23	chr17:20433187-20433237	HRE	kidney:	n/a
24	chr17:20445757-20445807	HRE	kidney:	n/a
25	chr17:20445757-20445807	HAEpiC	amniotic membrane:	n/a
26	chr17:20445757-20445807	Jurkat	blood:	n/a
27	chr17:20433187-20433237	Hepatocyte	liver:	n/a
28	chr17:20445757-20445807	AoSMC	blood vessel:	n/a
29	chr17:20433187-20433237	LNCaP	prostate:	n/a
30	chr17:20433187-20433237	NT2-D1	testis:	n/a
31	chr17:20433187-20433237	HCM	heart:	n/a
32	chr17:20433187-20433237	AG04449	skin:	fetal
33	chr17:20433187-20433237	SK-N-SH_RA	brain:	n/a
34	chr17:20445757-20445807	BE2_C	brain:	n/a
35	chr17:20445757-20445807	NT2-D1	testis:	n/a
36	chr17:20433187-20433237	NB4	blood:	n/a
37	chr17:20445757-20445807	A549	lung:	n/a
38	chr17:20433187-20433237	NHBE	bronchial:	n/a
39	chr17:20433187-20433237	HRCEpiC	kidney:	n/a
40	chr17:20433187-20433237	RPTEC	kidney:	n/a
41	chr17:20445757-20445807	HCPEpiC	choroid plexus:	n/a
42	chr17:20433187-20433237	GM12878	blood:	n/a
43	chr17:20433187-20433237	GM19239	blood:	n/a
44	chr17:20433187-20433237	BJ	skin:	n/a
45	chr17:20445757-20445807	ovcar-3	ovarian:	n/a
46	chr17:20445757-20445807	HPAEpiC	pulmonary alveolar:	n/a
47	chr17:20445757-20445807	HIPEpiC	eye:	n/a
48	chr17:20445757-20445807	HEEpiC	esophagus:	n/a
49	chr17:20433187-20433237	U87	brain:	n/a
50	chr17:20445757-20445807	Caco-2	colon:	n/a

No data

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LGALS9B-1	chr17:20433355-20434194	ENSG00000260907.1
2	lnc-LGALS9B-10	chr17:20435561-20436194	NONHSAT146584

No data

Variant related genes	Relation type
ENSG00000265916	TF binding region
ENSG00000205215	TF binding region
ENSG00000260907	TF binding region
ENSG00000267075	TF binding region
ENSG00000265916	CpG island
ENSG00000205215	CpG island
ENSG00000260907	CpG island
ENSG00000267075	CpG island

Extended variants
information (count: 480 )
Associated
traits (count: 150 )

Variant overlapped rSNPs/rCNVs (count:480 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs374412585	chr17:20432810-20432811	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs564349143	chr17:20432863-20432864	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs552920250	chr17:20432864-20432865	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs188564718	chr17:20432894-20432895	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs375422372	chr17:20432901-20432902	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs533327477	chr17:20432905-20432906	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs368012760	chr17:20432906-20432907	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs367929284	chr17:20432928-20432929	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs556783916	chr17:20432983-20432984	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs575469918	chr17:20433016-20433017	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs190525762	chr17:20433030-20433031	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs182730570	chr17:20433048-20433049	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs372401795	chr17:20433062-20433063	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs573158824	chr17:20433083-20433084	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs187008556	chr17:20433088-20433089	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs570192750	chr17:20433123-20433124	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs565277379	chr17:20433128-20433129	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs532402644	chr17:20433129-20433130	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs191437116	chr17:20433140-20433141	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs201411371	chr17:20433148-20433149	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs184467763	chr17:20433164-20433165	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs529403781	chr17:20433187-20433188	Enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs541089033	chr17:20433191-20433192	Enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs548353693	chr17:20433223-20433224	Enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs566760348	chr17:20433268-20433269	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs113559635	chr17:20433276-20433277	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs373188571	chr17:20433286-20433287	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs552643360	chr17:20433301-20433302	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs548446459	chr17:20433302-20433303	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs75033607	chr17:20433312-20433313	Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
31	rs533848192	chr17:20433323-20433324	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs575388164	chr17:20433396-20433397	Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
33	rs536385127	chr17:20433431-20433432	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
34	rs554794518	chr17:20433446-20433447	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs573120018	chr17:20433490-20433491	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
36	rs200222487	chr17:20433496-20433497	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
37	rs554004904	chr17:20433520-20433521	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
38	rs112941348	chr17:20433551-20433552	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
39	rs577132494	chr17:20433556-20433557	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs544303968	chr17:20433558-20433559	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
41	rs562932288	chr17:20433569-20433570	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
42	rs539453288	chr17:20433586-20433587	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs530120879	chr17:20433616-20433617	Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
44	rs541963256	chr17:20433717-20433718	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
45	rs560311886	chr17:20433720-20433721	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
46	rs527884332	chr17:20433738-20433739	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
47	rs552796132	chr17:20433744-20433745	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
48	rs371697286	chr17:20433756-20433757	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
49	rs571074978	chr17:20433757-20433758	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
50	rs532059614	chr17:20433775-20433776	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:150)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:232 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20432800-20433400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr17:20432800-20433800	Enhancers	HUES6 Cell Line	embryonic stem cell
3	chr17:20433200-20434400	Enhancers	HUES64 Cell Line	embryonic stem cell
4	chr17:20433400-20433600	Enhancers	Primary hematopoietic stem cells short term culture	blood
5	chr17:20433400-20434400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr17:20433600-20433800	Enhancers	H1 Cell Line	embryonic stem cell
7	chr17:20433600-20433800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr17:20433600-20434000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
9	chr17:20433600-20434200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
10	chr17:20433600-20434400	Enhancers	Dnd41	blood
11	chr17:20433800-20434000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
12	chr17:20433800-20434200	Enhancers	iPS-18 Cell Line	embryonic stem cell
13	chr17:20433800-20434400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr17:20433800-20437600	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
15	chr17:20434000-20434200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
16	chr17:20434000-20437600	Active TSS	HUES6 Cell Line	embryonic stem cell
17	chr17:20434200-20434400	Enhancers	HUES48 Cell Line	embryonic stem cell
18	chr17:20434200-20434400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr17:20434200-20434400	Enhancers	Primary B cells from peripheral blood	blood
20	chr17:20434200-20434400	Enhancers	Primary hematopoietic stem cells short term culture	blood
21	chr17:20434200-20434400	Enhancers	Primary T helper cells PMA-I stimulated	--
22	chr17:20434200-20434400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
23	chr17:20434200-20434400	Enhancers	A549	lung
24	chr17:20434200-20434400	Active TSS	Monocytes-CD14+_RO01746	blood
25	chr17:20434200-20437000	Active TSS	Fetal Adrenal Gland	Adrenal Gland
26	chr17:20434200-20437200	Active TSS	H9 Cell Line	embryonic stem cell
27	chr17:20434200-20437200	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
28	chr17:20434200-20437600	Active TSS	iPS-20b Cell Line	embryonic stem cell
29	chr17:20434200-20437600	Active TSS	Fetal Thymus	thymus
30	chr17:20434400-20434600	Active TSS	Primary B cells from cord blood	blood
31	chr17:20434400-20434600	Flanking Active TSS	Primary B cells from peripheral blood	blood
32	chr17:20434400-20434600	Enhancers	Primary T cells fromperipheralblood	blood
33	chr17:20434400-20434600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
34	chr17:20434400-20434600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
35	chr17:20434400-20434600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
36	chr17:20434400-20434600	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
37	chr17:20434400-20434600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
38	chr17:20434400-20434600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
39	chr17:20434400-20434600	Active TSS	NHEK	skin
40	chr17:20434400-20434800	Active TSS	ES-I3 Cell Line	embryonic stem cell
41	chr17:20434400-20434800	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr17:20434400-20434800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
43	chr17:20434400-20434800	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
44	chr17:20434400-20434800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr17:20434400-20434800	Active TSS	Primary T cells from cord blood	blood
46	chr17:20434400-20434800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
47	chr17:20434400-20434800	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
48	chr17:20434400-20434800	Active TSS	Fetal Lung	lung
49	chr17:20434400-20434800	Flanking Active TSS	A549	lung
50	chr17:20434400-20434800	Flanking Active TSS	Dnd41	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links